PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.
Yin ZX, Hang W, Liu G, Wang YS, Shen XF, Sun QH, Li DD, Jian YP, Zhang YH, Quan CS, Zeng Q, Li YL, Zhao RX, Ding Q, Xu ZX.
Yin ZX, et al. Among authors: liu g.
Oncotarget. 2017 Sep 26;9(2):1885-1897. doi: 10.18632/oncotarget.21277. eCollection 2018 Jan 5.
Oncotarget. 2017.
PMID: 29416738
Free PMC article.